RxDoctor Payments DataLook up a doctor →

Lawrence Robbins, MD

Neurology · Riverwoods, ILNPI 1770630212

Payments from drug & device makers

$281,074in general payments, 2019–2025

Across 1,617 payments — averaging $173.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$94K
  • Teva Pharmaceuticals USA, Inc.$44K
  • Idorsia Pharmaceuticals US Inc$20K
  • Lundbeck LLC$19K
  • Biohaven Pharmaceuticals, Inc.$19K
  • Eisai Inc.$18K
  • plus $68K from 42 others
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zydus Pharmaceuticals (USA) Inc.$900

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$281,074 in reported general payments places this provider in the 90th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$215,449
Medicare patients
236
Services billed
19,859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Riverwoods

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →